A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

Nancy Flores Biography and Net Worth

EVP of McKesson

Nancy Flores is Executive Vice President & Chief Information and Technology Officer for McKesson Corporation.

In this role, Flores is responsible for the company’s technology initiatives including software, infrastructure, application development tools and processes, operations, and cybersecurity. She also guides the overall direction for the company’s healthcare technology products and data and analytics.

Prior to McKesson, Flores served as CIO at Johnson Controls (JCI) where she was responsible for information technology, cybersecurity and analytics. Previously, she spent 22 years at Abbott in several leadership roles including chief information officer. She also led Global Business Services, Abbott’s back office services, through an extensive transformation.

The Greater Milwaukee Women’s Fund recognized Flores as a 2019 Futurist Leader for her strong commitment to diversity and inclusion. She also serves on the board of the Children’s Hospital of Wisconsin and is a member of the CIO Strategy Exchange (CIOSE), which is a selective program for chief information officers from forward-looking companies.

Flores earned bachelor’s degrees in Mathematics and Computer Information Systems from Regis University in Denver, Colorado and a master’s degree in Mathematics from the Colorado School of Mines in Golden, Colorado.

What is Nancy Flores' net worth?: The estimated net worth of Nancy Flores is at least $2.95 million as of May 31st, 2022. Ms. Flores owns 4,726 shares of McKesson stock worth more than $2,945,196 as of November 22nd. This net worth evaluation does not reflect any other assets that Ms. Flores may own. Learn More about Nancy Flores' net worth.
How do I contact Nancy Flores?: The corporate mailing address for Ms. Flores and other McKesson executives is 6555 STATE HWY 161, IRVING TX, 75039. McKesson can also be reached via phone at (972) 446-4800 and via email at [email protected]. Learn More on Nancy Flores' contact information.
Has Nancy Flores been buying or selling shares of McKesson?: Nancy Flores has not been actively trading shares of McKesson during the last quarter. Most recently, Nancy Flores sold 732 shares of the business's stock in a transaction on Tuesday, May 31st. The shares were sold at an average price of $330.69, for a transaction totalling $242,065.08. Following the completion of the sale, the executive vice president now directly owns 4,726 shares of the company's stock, valued at $1,562,840.94. Learn More on Nancy Flores' trading history.
Who are McKesson's active insiders?: McKesson's insider roster includes Nancy Avila (EVP), James Beer (CFO), Kevin Emerson (CAO), Tracy Faber (EVP), Nancy Flores (EVP), John Hammergren (Chairman), Marie Knowles (Director), Erin Lampert (SVP), Maria Martinez (Director), Sundeep Reddy (SVP), Thomas Rodgers (EVP), Susan Salka (Director), Lori Schechter (EVP), LeAnn Smith (EVP), Brian Tyler (CEO), Brian Tyler (CEO), and Britt Vitalone (CFO). Learn More on McKesson's active insiders.
Are insiders buying or selling shares of McKesson?: During the last twelve months, insiders at the sold shares 16 times. They sold a total of 54,758 shares worth more than $29,793,638.34. The most recent insider tranaction occured on September, 5th when CEO Brian S Tyler sold 3,753 shares worth more than $2,105,808.30. Insiders at McKesson own 0.1% of the company. Learn More about insider trades at McKesson.
Information on this page was last updated on 9/5/2024.

Nancy Flores Insider Trading History at McKesson

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/31/2022	Sell	732	$330.69	$242,065.08	4,726
4/7/2022	Sell	3,298	$311.09	$1,025,974.82	5,440

Nancy Flores Buying and Selling Activity at McKesson

McKesson Company Overview

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Today's Range

Now: $623.19

$622.07

$632.59

50 Day Range

MA: $530.98

$479.05

$628.15

2 Week Range

Now: $623.19

$431.35

$637.51

Volume

510,419 shs

Average Volume

818,590 shs

Market Capitalization

$79.11 billion

P/E Ratio

32.27

Dividend Yield

0.46%

Beta

0.44

War on Elon Escalates…

From Porter & Company | Ad